APA aipamena

Borin, M. T., Barnes, C. N., Darpo, B., Pendyala, S., Xue, H., & Bourdet, D. L. (2019). Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study. Clin Pharmacol Drug Dev.

Chicago Style aipamena

Borin, Marie T., Chris N. Barnes, Borje Darpo, Srikanth Pendyala, Hongqi Xue, and David L. Bourdet. "Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study." Clin Pharmacol Drug Dev 2019.

MLA aipamena

Borin, Marie T., et al. "Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study." Clin Pharmacol Drug Dev 2019.